Latest Article

I will never let my guard down. It doesn’t mean I am over-the-top nuts (depending on who you ask, naturally), following all that my program comprises, though I am quite disciplined. Put simply, I am serious about maintaining my health, and hope to avoid a relapse, or the possibility of being diagnosed with another disease, be that a secondary cancer or some other condition(s) in the future.

Recent Articles

We still know so little about the brain. And though this figure is controversial, it is widely thought that humans only use 10% of the capacity of their brains. One thing we do know about the brain is that it contains a natural pharmacy comprising some powerful, positive (and negative) chemicals.

A recently published survey of primary care physician (PCPs) showed how ambivalent many doctors are to discuss cancer treatment options with their patients. Glenn shares his views on how and where a PCP best fits into the cancer management team.

Being a horrible host to cancer means making it as uncomfortable as possible for the unwanted visitor to hang out, to grow, to take control of your ‘home’—your host environment. Here’s a reading list to get you on your way.

I’m not a fan of the ‘fighting cancer’ metaphor as a battle cry; scores tallied—winners and losers. I prefer the judo allegory: leveraging one’s full, innate healing capacity—utilizing numerous tools and approaches—to make cancer, or any other condition or pathology, more difficult to take root or gain an upper hand. For those with cancer, it’s […]

There is good news in the advancement of chemo-free approaches to managing chronic lymphocytic leukemia, and I am thrilled to share it with you. Results of the phase III ECOG trial found that the combination of ibrutinib (Imbruvica) plus rituximab (Rituxan) came out superior to the chemotherapy and immunotherapy (chemoimmunotherapy) grouping of fludarabine, cyclophosphamide, and rituximab, known as FCR.

A new, troubling report from Truth In Advertising suggests some cancer hospitals are guilty of deceiving patients about their chances of survival, because they give the initial impression that the patient will be treated under the umbrella of precision cancer care, when, in fact, it (precision cancer care) is not available for many types of cancer.

Does the consumption of ‘clean’ foods do a better job at preventing cancer than, say, what the majority of the U.S. population eats—namely produce and processed foodstuffs containing pesticide and herbicide residue, antibiotics, and growth hormones?

Glenn shares how THC and CBD are being used in a clinical setting—and where we are in terms of current science supporting medical marijuana and CBD oil for symptom relief and as an anticancer agent. He also shares his own history with cannabinoids.